Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fennec Pharmaceuticals (FENC)
NASDAQ:FENC
Fennec Pharmaceuticals (FENC) Stock Price & Analysis
177 Followers
FENC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$7.02 - $10.85
Previous Close$7.15
Volume117.33K
Average Volume (3M)57.07K
Market Cap
$245.43M
Enterprise Value$246.56M
Total Cash (Recent Filing)$23.77M
Total Debt (Recent Filing)$24.90M
Price to Earnings (P/E)-7.1
Beta0.18
Next Earnings
Nov 14, 2023EPS Estimate
-$0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.00
Shares Outstanding26,361,399
10 Day Avg. Volume73,452
30 Day Avg. Volume57,069
Standard Deviation0.14
R-Squared0.00930
Alpha0.00623
Financial Highlights & Ratios
Price to Book (P/B)-103.54
Price to Sales (P/S)90.49
Price to Cash Flow (P/CF)-9.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue160.62
Enterprise Value/Gross Profit170.16
Enterprise Value/Ebitda-16.70
Forecast
1Y Price Target
$16.00Price Target Upside113.05% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Fennec Pharmaceuticals News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
FENC FAQ
What was Fennec Pharmaceuticals’s price range in the past 12 months?
Fennec Pharmaceuticals lowest stock price was $7.02 and its highest was $10.85 in the past 12 months.
What is Fennec Pharmaceuticals’s market cap?
Currently, no data Available
When is Fennec Pharmaceuticals’s upcoming earnings report date?
Fennec Pharmaceuticals’s upcoming earnings report date is Nov 14, 2023 which is in 45 days.
How were Fennec Pharmaceuticals’s earnings last quarter?
Fennec Pharmaceuticals released its earnings results on Aug 03, 2023. The company reported -$0.21 earnings per share for the quarter, missing the consensus estimate of -$0.157 by -$0.053.
Is Fennec Pharmaceuticals overvalued?
According to Wall Street analysts Fennec Pharmaceuticals’s price is currently Undervalued.
Does Fennec Pharmaceuticals pay dividends?
Fennec Pharmaceuticals does not currently pay dividends.
What is Fennec Pharmaceuticals’s EPS estimate?
Fennec Pharmaceuticals’s EPS estimate is -$0.11.
How many shares outstanding does Fennec Pharmaceuticals have?
Fennec Pharmaceuticals has 26,566,467 shares outstanding.
What happened to Fennec Pharmaceuticals’s price movement after its last earnings report?
Fennec Pharmaceuticals reported an EPS of -$0.21 in its last earnings report, missing expectations of -$0.157. Following the earnings report the stock price went down -7.292%.
Which hedge fund is a major shareholder of Fennec Pharmaceuticals?
Currently, no hedge funds are holding shares in FENC
---
Fennec Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$16.00 (113.05% Upside)
$16.00 (113.05% Upside)
Blogger Sentiment
Neutral
FENC Sentiment 50%
Sector Average 68%
Sector Average 68%
Insider Transactions
Sold Shares
Worth $304.0K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-4.15%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
24.85%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Fennec Pharmaceuticals
Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.
---
Top 5 ETFs holding FENC
Vanguard Russell 3000 ETF
$9.43K
Up to five ETFs with an Outperform Smart Score that hold FENC. The ETFs are listed according to market value of FENC within the ETF
---